Robert J Olson (Robert A Olson, Robert Olson)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Venues

Current oncology (Toronto, Ont.)

Journal of breast cancer

BMC cancer

Healthcare management forum

University of British Columbia Faculty of Medicine

Harvard School of Public Health (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of British Columbia Faculty of Medicine Jan 01 2017

Canada

Division Head :: Radiation Oncology [Dept of Surgery]

BC Cancer Agency Centre for the North Nov 01 2012

Canada

Department Head :: Radiation Oncology

Education History

Harvard School of Public Health Jun 01 2009 - Sep 01 2010

United States

MSC :: Epidemiology

Publications

Jeongshim Lee, Ji Hyoung Kim, Mitchell Liu, Andrew Bang, Robert J Olson, Jee Suk Chang
Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer. Journal of breast cancer 27 (2) (2024)
Jeongshim Lee, Ji Hyoung Kim, Mitchell Liu, Andrew Bang, Robert J Olson, Jee Suk Chang
Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer. Journal of breast cancer 27 (2) (2024)
Jeongshim Lee, Ji Hyoung Kim, Mitchell Liu, Andrew Bang, Robert J Olson, Jee Suk Chang
Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer. Journal of breast cancer (2024)
Jeongshim Lee, Ji Hyoung Kim, Mitchell Liu, Andrew Bang, Robert J Olson, Jee Suk Chang
Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer. Journal of breast cancer 27 (2) (2024)
Jeongshim Lee, Ji Hyoung Kim, Mitchell Liu, Andrew Bang, Robert J Olson, Jee Suk Chang
Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer. Journal of breast cancer 27 (2) (2024)
Ryan Urban, Justin Wong, Peter Lim, Susan Zhang, Ingrid Spadinger, Robert J Olson, Francois Bachand, Clement Ho, Sarah A Cook, Lovedeep Gondara, Sarah Nicole Hamilton
Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy. Journal of gynecologic oncology 33 (5) (2022)
Cheryl Duzenli, Elisa K Chan, Theodora Koulis, Sheri Grahame, Joel Singer, David Morris, Josslynn Spence, Terry Lee, Levi Burns, Robert J Olson
Validation of a Patient-Reported Outcome Measure for Moist Desquamation among Breast Radiotherapy Patients. Current oncology (Toronto, Ont.) 29 (7) (2022)
Matthew Chan, Robert J Olson, Vincent Lapointe, Jeremy Hamm, Francois Bachand, Caroline Holloway, Christina Parsons, Peter Lim
Using a Weekly Patient-Reported Outcome Questionnaire to Track Acute Toxicity in Patients Undergoing Pelvic Radiotherapy for Gynecologic Cancers. Current oncology (Toronto, Ont.) 29 (5) (2022)
Ling Yan, Alan Nichol, Robert J Olson
Validation of the BC-Brain Patient-Reported Outcome Questionnaire for Patients with Central Nervous System Tumours Treated with Radiotherapy. Current oncology (Toronto, Ont.) 29 (4) (2022)
Robert J Olson, Vincent LaPointe, Alex Benny, Matthew Chan, Shilo Lefresne, Michael McKenzie
Evaluation of Patient-Reported Outcome Differences by Radiotherapy Techniques for Bone Metastases in A Population-Based Healthcare System. Current oncology (Toronto, Ont.) 29 (3) (2022)
Amanda Caissie, Robert J Olson, Lisa Barbera, Jennifer O'Donnell, Carol-Anne Davis, Jennifer Croke, Louise Bird, John Kildea, Erika Brown, Michael Brundage, Michael Milosevic
Striving to Fill in Gaps between Clinical Practice and Standards: The Evolution of a Pan-Canadian Approach to Patient-Reported Outcomes Use. Current oncology (Toronto, Ont.) 29 (5) (2022)
Nathalie Bodin, Heidi R Pethybridge, Leanne M Duffy, Anne Lorrain, Valérie Allain, John M Logan, Frédéric Ménard, Brittany Graham, C Anela Choy, Christopher J Somes, Robert J Olson, Jock W Young
Global data set for nitrogen and carbon stable isotopes of tunas. Ecology 102 (3) (2021)
Robert J Olson, Mary McLay, Jeremy Hamm, Russell C Callaghan
Identification of Tobacco-Related Cancer Diagnoses among Individuals with Psychiatric Disorders: A Population-Based Matched Cohort Study Using a Competing Risks Approach from British Columbia. Current oncology (Toronto, Ont.) 28 (6) (2021)
Robert J Olson, Lindsay Mathews, Mitchell Liu, Devin Schellenberg, Benjamin Mou, Tanya Berrang, Stephen Harrow, Rohann J M Correa, Vasudeva Bhat, Howard Pai, Islam Mohamed, Stacy Miller, Famke Schneiders, Joanna Laba, Derek Wilke, Sashendra Senthi, Alexander V Louie, Anand Swaminath, Anthony Chalmers, Stewart Gaede, Andrew Warner, Tanja D de Gruijl, Alison Allan, David A Palma
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial. BMC cancer 20 (1) (2020)
Robert J Olson, Roel Schlijper, Nick Chng, Quinn Matthews, Marco Arimare, Lindsay Mathews, Fred Hsu, Tanya Berrang, Alexander Louie, Benjamin Mou, Boris Valev, Joanna Laba, David Palma, Devin Schellenberg, Shilo Lefresne
SUPR-3D: A randomized phase iii trial comparing simple unplanned palliative radiotherapy versus 3d conformal radiotherapy for patients with bone metastases: study protocol. BMC cancer 19 (1) (2019)
Robert J Olson, Fuchsia Howard, Vincent Lapointe, Devin Schellenberg, Alan Nichol, Gale Bowering, Susan Curtis, Allison Walter, Steven Brown, Corinne Thompson, Jackie Bergin, Sheri Lomas, John French, Ross Halperin, Scott Tyldesley, Wayne Beckham
Provincial development of a patient-reported outcome initiative to guide patient care, quality improvement, and research. Healthcare management forum 31 (1) (2019)
Robert J Olson, Mitchell Liu, Alanah Bergman, Sonya Lam, Fred Hsu, Benjamin Mou, Tanya Berrang, Ante Mestrovic, Nick Chng, Derek Hyde, Quinn Matthews, Chad Lund, Daniel Glick, Howard Pai, Parminder Basran, Hannah Carolan, Boris Valev, Shilo Lefresene, Scott Tyldesley, Devin Schellenberg
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5. BMC cancer 18 (1) (2018)

Robert J Olson.css-eqlu8i{font-size:small;padding-left:4px;} (Robert A Olson, Robert Olson)

Publication Activity (10 Years)

Top Topics

Top Venues

Robert J Olson (Robert A Olson, Robert Olson)